Resumen
En este artículo se hace una revisión de la relación entre epilepsia y deterioro cognitivo, al igual que los aspectos relacionados con los medicamentos anticonvulsivantes y su interacción en la memoria, aprendizaje, estado de ánimo, etc.
Citas
Engel J, Taylor DC. Neurobioly of behaviour disorder. In: Engel J, Pedley T. Epilepsy a Comprehensive Texbook. Philadelphia: Lippincott Raven press; 1997:2045-2052
Johnston M. Neurotransmitters and epilepsy. In: Wyllie E. The Treatment of epilepsy: principles and practice. Philadelphia: Lea & Febiger; 1993: 111-125.
Seidenberg M, O’Leary D, Berent S, Boll T. Changes in Seizure Frecuency and Test-Retest Scores on the Wechsler Adult Intelligence Scale. Epilepsia 1981, 22; 75-83
Dodril CB. Neuropsychological effects of seizures, Epilepsy & Behavior 2004; S21-S24
Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic Epilepsy and Cognition: A Longitudinal Study in Temporal Lobe Epilepsy. Ann Neurol 2003; 54:425-432
Bourgeois BDF, Prensky AL, Palkes HS, Talent BK Buxsh SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983; 14: 438-44
Bourgeois BDF. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004; Suppl 1: S15-24
Besug FMC. Reading abilities on cognitive functions of chidren with epilepsy: influence of epileptic syndromes. Brain Dev 2006; 28: 122-30
Lindgren S, Kihlgren M, Melin L, et al. Development of cognitive functions in children with rolandic epilepsy. Epilepsy & Behavior 2004; 5: 903-10
Ortinski P, Kimford MD. Cognitive side effects of antiepileptic drugs. Epilepsy & Behavior 2003; S60-65
Glauser TA. Topiramate. Epilepsia 1999; 40: S71-S80.
Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005; 64:792-798
Werz MA, Schoenberg MR, Meador KJ, Loring DW, Ray PG. Subjective preference for lamotrigine or topiramate in healthy volunteers: relationship to cognitive and behaviour functioning. Epilepsy & Behavior 2006; 8: 181-191
Lamotrigine for generalized seizures associated with Lennox-gastaut syndrome NEJM 1997; 337: 1807-1812
Aldenkamp A, De Krom M, Reijs R. Newer Antiepileptic drugs and cognitive issues. Epilepsia 2003: 44: 21-29.
Morris GL. Gabapentin. Epilepsia 1999; 40: S63-S70.
Lynch BA, Lambeng N, Nocka K, et al. The synaptic vesicle protein SV2A is binding site for the antiepileptic drug levetiracetam. PANS 2004; 101(26):9861-66.
Cramer JA, Van Hammee K et al. Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam. Epilepsy & Behavior 2003; 4: 118-123.
French SJ, Fought E, et al. Practice advisory: that use of felbamato in treatment of patients with intractable epilepsy. Epilepsia 1999; 40: 803-808.
Reijs R, Aldenkamp AP, De Krom M. Mood effects of antiepileptic drugs. Epilepsy & Behavior 2004; 5: S66-S76.
Honny A, Litzinger MJ. Tiagabine add-on treatment improves neurobehavioral and epilepsy-related syntoms in pediatric seizures patients. Epilepsia 1997;38: S208.
Livingston J, Beaumont D, et al. Vigabatrin in the treatment of epilepsy in children. Br J. Clin Pharmacol 1989; 27:1095-1125.
Aldenkamp AP, Alpherts WC. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 2006; 47(7): 1153-1159.
Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cognition. Lancet 2004;3(11): 663-672.
Kalviainen R. Cognitive effects of GABAergic antiepileptics drugs. Electroencephalografhy and clinical neurophysiology. 1997;103: 51-59.
Willmore LJ, UedaY. Molecular biology on genetics of epilepsy. Acta Med Okayana 2002; 56(2): 57-58.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.